California Removes 900,000 People From Health Care Plan
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Hundreds of thousands have been removed from a health care plan in California over the course of two years, according to data from KFF, a nonprofit health policy research and news organization.
About 900,000 Americans were disenrolled from Medicaid in the state as part of the unwinding process happening nationwide after Medicaid coverage was expanded following the COVID-19 pandemic.
Newsweek has contacted the California Department of Public Health via email for comment.
Why It Matters
The unwinding process has resulted in significant drops in Medicaid enrollment across the U.S. There is now growing concern about the rising population of those without health insurance and the wider impacts this could have, such as worsening health outcomes, increasing strain on emergency services and rising medical costs.
The worry has been amplified by the recent passing of President Donald Trump's One Big Beautiful Bill, in which funding cuts, a focus on "waste, fraud and abuse" and work requirements are in store for Medicaid. Many have voiced concern that the measures will result in millions losing health coverage.
File photo: A doctor walks with a young boy through a hospital.
File photo: A doctor walks with a young boy through a hospital.What To Know
In California, there were 14,285,643 covered by Medicaid in March 2023, but by March 2025, that number was 13,392,566, KFF data shows.
This was because during the pandemic, some states expanded Medicaid coverage under the Affordable Care Act (ACA), causing nationwide enrollment levels to increase.
Federal rules forced states to keep most Medicaid enrollees on the program, even if their eligibility status changed, until March 2023, when they were then allowed to start rolling recipients off the program.
This marks a change of about 900,000, a decline that was smaller than other highly populated states like Texas, Florida and New York.
In March 2025, the number of people with Medicaid coverage in California was still higher than pre-pandemic levels, by 16 percent.
The reason why Medicaid coverage is unwinding at different rates in states is because "states approached the process of reviewing the eligibility of their Medicaid beneficiaries with fundamentally different strategies," Michael Sparer, professor and chair of the Department of Health Policy and Management at Columbia University, told Newsweek.
He said that Florida and Texas began the review process "as fast as they could and immediately declared ineligible those beneficiaries who did not promptly respond to review notices."
"There is clear evidence that many beneficiaries who were still eligible lost coverage simply because they did not timely navigate the administrative hurdles to recertification," he added.
Meanwhile, he said that New York and California "were far more deliberate in how they approached the review process, thus the number who've lost their eligibility via this process is far fewer."
What People Are Saying
Michael Sparer, professor and chair of the Department of Health Policy and Management at Columbia University, told Newsweek: "Medicaid enrollment surged during the pandemic for several reasons, including increased unemployment combined with a requirement that in exchange for additional federal funding, states could not recertify beneficiary eligibility until the "public health emergency" was declared over. Put simply, millions signed up during the pandemic and their eligibility could only be reviewed beginning in the spring 2023.
"There is reason to be quite concerned about how this has played out and also what it suggests may happen when Medicaid work requirements, which create their own set of administrative hurdles, are implemented. First, persons who are eligible for coverage should not lose coverage. Bad health outcomes will follow. Second, persons who are no longer Medicaid eligible should be guided to other options, such as subsidized ACA marketplace coverage. Finally, the variation in how states conduct Medicaid eligibility reviews leads to unfortunate inequities."
What Happens Next
As the unwinding continues, more reductions in enrollment are expected in California and across the country. With millions already having lost health coverage, concerns remain about access to care for low-income individuals and families.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
a minute ago
- Axios
What to know about rising COVID-19 cases and the surging "stratus" variant
COVID-19 cases are rising again in the United States, and the "stratus" variant might be to blame. The big picture: A summer outbreak of COVID-19 cases isn't a shocker. But it's arriving before children head back to school, where the virus could spread even more. The risk of a summertime COVID-19 wave comes after Health Secretary Robert F. Kennedy Jr. unilaterally changed federal COVID vaccine recommendations, causing confusion over who should get the shots. COVID-19 cases rising in U.S. Driving the news: The Centers for Disease Control and Prevention on Friday upgraded national wastewater viral activity for COVID-19 from "low" to "moderate." Wastewater levels for COVID-19 are highest in the Western U.S., according to a CDC map, with levels peaking in Alaska, California, Colorado, Nevada and Utah. The Southeast also has higher wastewater activity levels, with Louisiana having the most nationwide, according to CDC data recorded from July 27 to Aug. 2. What they're saying: "Wastewater monitoring can detect viruses spreading from one person to another within a community earlier than clinical testing and before people who are sick go to their doctor or hospital," the CDC says on its website. "It can also detect infections without symptoms. If you see increased wastewater viral activity levels, it might indicate that there is a higher risk of infection." By the numbers: The CDC estimated Friday that COVID-19 cases are likely growing across 45 states. Only four states — Alaska, North Dakota, Maine and New Hampshire — measured as having no change in COVID-19 cases. Wyoming's numbers were not estimated. Though the N.B.1.8.1 variant (nicknamed "nimbus") is still the dominant variant in the U.S., the recent climb might be related to the variant XFG, commonly known as "Stratus." Both are descendants of the Omicron strain. What to know about the "stratus" COVID variant Flashback: The XFG "stratus" variant was first dedicated in January, according to the World Health Organization. The variant made little noise in the United States during the first half of the year. However, in June, the "stratus" variant accounted for 14% of cases, according to the CDC, which is the third-highest among all variants. XFG is a combination of the LF.7 and LP.8.1.2 variants, the latter of which is the second-most prominent strain in the U.S., per the CDC. Yes, but: Though the WHO has placed XFG on its watchlist, and it may be more adept at evading our immune defenses, the "stratus" variant was deemed as a "low" public health risk as recent as June. Are "Stratus" variant symptoms different? The "stratus" variant symptoms haven't been seen as any different than other recent COVID-19 variants. The common COVID-19 symptoms outlined by the CDC — fever, chills, cough, sore throat and congestion — still apply.
The Hill
31 minutes ago
- The Hill
FDA says IV saline shortage is over
A longtime shortage of a type of sterile intravenous saline is now resolved, the Food and Drug Administration announced Friday. According to the FDA, sodium chloride 0.9% injection products have been in shortage since 2018. The shortage was exacerbated when Hurricane Helene flooded a Baxter manufacturing plant in Marion, N.C. last fall what was responsible for 60 percent of the IV fluid in the country. 'This marks a significant milestone for public health and reinforces the FDA's commitment to ensuring Americans have consistent access to life-saving medical products,' FDA Commissioner Marty Makary said in a statement. Hospitals were left scrambling in the aftermath of Helene, as the shortage of multiple types IV fluid highlighted the fragility and vulnerability of the country's medical supply chain. Many were forced to curtail elective procedures and ration supplies. The IV fluid market is made up of primarily four manufacturers: Baxter International, which makes about 60 percent; B. Braun Medical, which makes about 23 percent; along with ICU Medical and Fresenius Kabi. It's common to see the same products go on and off the shortage list for years. Prior to Helene, certain IV solutions had been in shortage for almost 10 years. Experts have long warned about allowing critical supplies to be highly concentrated in one place. But manufacturing requirements for sterility mean a high barrier to entry into the market, and with low returns on investment for manufacturers, hospitals and suppliers have few options for recourse. The FDA said it is working closely with manufacturers and will continue to monitor the supply of other IV fluids, which are still in shortage. 'The availability of reliable medical products is essential to patient care and the overall resilience of our healthcare system. Addressing this shortage has been a top priority for the FDA,' Makary said.
Newsweek
32 minutes ago
- Newsweek
Medicare Will Start Using AI to Help Make Coverage Decisions Next Year
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Starting in January, Medicare will test out an artificial intelligence (AI) pilot program to decide whether patients get certain procedures covered or not. The Centers for Medicare & Medicaid Services (CMS) will use AI to help make prior authorization decisions via the new Wasteful and Inappropriate Service Reduction (WISeR) Model, but the final decision will be made by an employee, according to the agency. Why It Matters AI has made a significant impact in the workforce, education, health care and beyond. While some remain hesitant about its usage and the possibility of it eliminating human jobs, AI tools have been linked to greater efficiency for many companies. While traditional Medicare has typically had fewer prior authorization requirements than Medicare Advantage, the use of AI could speed up coverage decisions and also potentially lead to higher denials of coverage, experts say. A sign in front of the Centers for Medicare & Medicaid Services building is pictured on March 19 in Woodlawn, Maryland. A sign in front of the Centers for Medicare & Medicaid Services building is pictured on March 19 in Woodlawn, To Know While the final decision by Medicare to approve or deny coverage will come down to an employee, critics of the AI test pilot say that companies conducting the review process will be incentivized to deny coverage because they receive payments when they lower costs. The move toward AI arrives as the Trump administration has made it a priority to reduce government fraud and waste, and Medicare Part B premiums are likely to increase by $21.50 per month, from $185 in 2025 to $206.50 in 2026, according to MarketWatch. Some of the specific services included in the AI-powered prior authorization decisions will be skin and tissue substitutes, electrical nerve-stimulator implants and knee arthroscopy for knee osteoarthritis. In the past, traditional Medicare enrollees face fewer prior authorization decisions. The average number of them required per Medicare Advantage enrollee was two in 2023, compared to just one review per 100 traditional Medicare beneficiaries. "For seniors, the impact could be substantial, especially when immediate care is critical," Kevin Thompson, CEO of 9i Capital Group and host of the 9innings podcast, told Newsweek. "The current administration is focused on removing so-called waste, fraud, and abuse, pulling every lever to show their program is working. What used to require a single prior authorization could now face multiple layers, which means more delays and higher denial rates." The AI pilot will take place over the next six years and will not apply to inpatient-only services or for procedures that carry high risks if delayed. At the moment, the pilot program is limited to Arizona, New Jersey, Ohio, Oklahoma, Texas and Washington. What People Are Saying CMS Administrator Dr. Mehmet Oz, in a statement: "CMS is committed to crushing fraud, waste, and abuse, and the WISeR Model will help root out waste in Original Medicare. Combining the speed of technology and the experienced clinicians, this new model helps bring Medicare into the 21st century by testing a streamlined prior authorization process, while protecting Medicare beneficiaries from being given unnecessary and often costly procedures." Alex Beene, financial literacy instructor for the University of Tennessee at Martin, told Newsweek: "For many Americans, the term 'Medicare Advantage' has left them asking what the real advantage was, as plans haven't worked out in some parts of the country as efficiently as originally promised. With that in mind, the announcement Medicare will start piloting the use of AI as a possible pre-authorization procedure for potential recipients in six states and the citing of Medicare Advantage's additional authorization steps is raising concerns - and rightfully so." Thompson also told Newsweek: "AI may speed up processing times in theory, but mistakes are inevitable. The bigger concern is how the financial incentives are structured. If contractors are rewarded for reducing or denying coverage, that's exactly what will happen—more denials. It's as simple as following the money. Whether a treatment is truly necessary or not becomes secondary to the incentive structure." What Happens Next The AI usage could have significant impacts on the number of procedures that Medicare beneficiaries get approved for coverage. According to a 2024 Senate committee report, AI tools have been linked to higher rates of care denial, 16 times higher than decisions made without the technology. "Medicare recipients want an easy process with as many barriers removed as possible when qualifying and receiving services," Beene said. "AI can certainly be used to refine the process, but as it's been presented, there's justification for the red flags being raised."
